{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:10Z","timestamp":1791235330366,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013873","name":"Ontario Government","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013873","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Sciences and Engineering Council of Canada"},{"name":"London Run for Ovarian Cancer"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/objectives: Epithelial ovarian cancer (EOC) is the deadliest gynaecologic malignancy, largely due to late-stage diagnosis and ineffective therapy. EOC commonly spreads through the peritoneal cavity as multicellular spheroids, which are metastatic structures that enhance survival under detachment stress, promote dissemination, and contribute to therapeutic resistance. We previously showed that ULK1, a serine\/threonine kinase classically linked to macroautophagy initiation, supports EOC progression, suggesting non-canonical roles in spheroid biology and pathogenesis. Methods: CRISPR\/Cas9 ULK1 knockout (ULK1KO) models were generated in OVCAR8, HEYA8, and ES2 cells. Mitochondrial degradation phenotypes were assessed in spheroids by immunoblotting and fluorescence microscopy. Label-free proteomics with bioinformatic pathway analysis identified ULK1-associated programs in EOC spheroids. Bioenergetic consequences were quantified using Seahorse ATP-Rate assays. Therapeutic interactions were evaluated using multi-dose combination matrices testing the ULK1 inhibitor DCC-3116 with metformin. Results: ULK1 modulated mitochondrial degradation in a cell-line-specific manner, either promoting or protecting against mitochondrial loss through mechanisms that were uncoupled from canonical autophagy machinery. Proteomic and bioinformatic analyses revealed significant alterations in mitochondria-related processes, aligning with emerging ULK1 functions in mitochondrial homeostasis. ULK1 loss broadly reduced OXPHOS complex proteins in EOC spheroids and consistently decreased hexokinase 2 (HK2), indicating coordinated metabolic remodeling. Seahorse profiling mirrored these shifts: OVCAR8 ULK1KO spheroids showed reduced OCR and ATP production, whereas HEYA8 and ES2 ULK1KO spheroids exhibited increased mitochondrial ATP production. Combination matrices showed potential synergy between DCC-3116 and metformin. Conclusions: These data show that ULK1 differentially regulates mitochondrial degradation across EOC spheroid models through potential mechanisms alternative to canonical autophagy machinery, while reshaping spheroid metabolism and revealing potential therapeutic vulnerabilities in advanced EOC.<\/jats:p>","DOI":"10.3390\/cancers18111746","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:03:27Z","timestamp":1779879807000},"page":"1746","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Divergent Role of ULK1 to Balance Mitochondrial Homeostasis and Bioenergetics in Ovarian Cancer Spheroids"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0365-6880","authenticated-orcid":false,"given":"Jack D.","family":"Webb","sequence":"first","affiliation":[{"name":"The Mary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON N6A 5W9, Canada"},{"name":"Department of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8996-4436","authenticated-orcid":false,"given":"Matthew J.","family":"Borrelli","sequence":"additional","affiliation":[{"name":"The Mary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON N6A 5W9, Canada"},{"name":"Department of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudith Ramos","family":"Vald\u00e9s","sequence":"additional","affiliation":[{"name":"The Mary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON N6A 5W9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1853-8066","authenticated-orcid":false,"given":"Trevor G.","family":"Shepherd","sequence":"additional","affiliation":[{"name":"The Mary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON N6A 5W9, Canada"},{"name":"Department of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Department of Obstetrics & Gynaecology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1503\/cmaj.191292","article-title":"Projected estimates of cancer in Canada in 2020","volume":"192","author":"Brenner","year":"2020","journal-title":"Can. Med. Assoc. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2013.321","article-title":"Epithelial ovarian cancer experimental models","volume":"33","author":"Lengyel","year":"2013","journal-title":"Oncogene"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: Integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","article-title":"Multicellular spheroids in ovarian cancer metastases: Biology and pathology","volume":"113","author":"Shield","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov."},{"key":"ref_7","first-page":"1384","article-title":"Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids","volume":"10","author":"Singha","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41388-026-03702-2","article-title":"ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer","volume":"45","author":"Webb","year":"2026","journal-title":"Oncogene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.semcancer.2013.05.007","article-title":"Autophagosome formation\u2014The role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage","volume":"23","author":"Wirth","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1038\/s41467-018-05449-1","article-title":"Phosphorylation of ULK1 affects autophagosome fusion and links chaperone-mediated autophagy to macroautophagy","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/auto.23323","article-title":"The ULK1 complex sensing nutrient signals for autophagy activation","volume":"9","author":"Wong","year":"2013","journal-title":"Autophagy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ncb2757","article-title":"ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase","volume":"15","author":"Russell","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the Pathogenesis of Disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/febs.13820","article-title":"Mitochondrial biogenesis and clearance: A balancing act","volume":"284","author":"Ploumi","year":"2017","journal-title":"FEBS J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and Cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bordi, M., Nazio, F., and Campello, S. (2017). The Close interconnection between mitochondrial dynamics and mitophagy in cancer. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00081"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1515\/hsz-2012-0119","article-title":"Mitophagy: Mechanisms, pathophysiological roles, and analysis","volume":"393","author":"Ding","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Grieco, J.P., Compton, S.L.E., Bano, N., Brookover, L., Nichenko, A.S., Drake, J.C., and Schmelz, E.M. (2023). Mitochondrial plasticity supports proliferative outgrowth and invasion of ovarian cancer spheroids during adhesion. Front. Oncol., 19 12.","DOI":"10.3389\/fonc.2022.1043670"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.molcel.2011.06.018","article-title":"Hsp90-Cdc37 Chaperone Complex Regulates Ulk1- and Atg13-Mediated Mitophagy","volume":"43","author":"Joo","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/embr.201438501","article-title":"ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy","volume":"15","author":"Wu","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.febslet.2015.05.020","article-title":"Phosphorylation of ULK1 by AMPK regulates translocation of ULK1 to mitochondria and mitophagy","volume":"589","author":"Tian","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41419-024-06477-0","article-title":"Regulation of ULK1 by WTAP\/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2016.04.009","article-title":"ULK1\/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy","volume":"62","author":"Li","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"eabd5016","DOI":"10.1126\/scitranslmed.abd5016","article-title":"ULK1 inhibition promotes oxidative stress\u2013induced differentiation and sensitizes leukemic stem cells to targeted therapy","volume":"13","author":"Ianniciello","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"110904","DOI":"10.1016\/j.cbi.2024.110904","article-title":"Trifluoperazine activates AMPK\/mTOR\/ULK1 signaling pathway to induce mitophagy in osteosarcoma cells","volume":"392","author":"Shen","year":"2024","journal-title":"Chem.-Biol. Interact."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"109321","DOI":"10.1016\/j.isci.2024.109321","article-title":"AP39 through AMPK-ULK1-FUNDC1 pathway regulates mitophagy, inhibits pyroptosis, and improves doxorubicin-induced myocardial fibrosis","volume":"27","author":"Zhao","year":"2024","journal-title":"iScience"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41418-025-01492-w","article-title":"TTK promotes mitophagy by regulating ULK1 phosphorylation and pre-mRNA splicing to inhibit mitochondrial apoptosis in bladder cancer","volume":"32","author":"Chen","year":"2025","journal-title":"Cell Death Differ."},{"key":"ref_29","unstructured":"Borrelli Matthew, J. (2024). An Examination of Adaptive, Metabolism-Associated Cellular Reprogramming in Epithelial Ovarian Cancer Spheroids. [Ph.D. Thesis, Western University Open Repository]."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"167312","DOI":"10.1016\/j.bbadis.2024.167312","article-title":"Metabolic adaptation in epithelial ovarian cancer metastasis","volume":"1870","author":"Frederick","year":"2024","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/embor.2008.238","article-title":"PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation","volume":"10","author":"Kajihara","year":"2009","journal-title":"EMBO Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100987","DOI":"10.1016\/j.crmeth.2025.100987","article-title":"Spatiotemporal analysis of ratiometric biosensors in live multicellular spheroids using SPoRTS","volume":"5","author":"Borrelli","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: A graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The Reactome Pathway Knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e4321","DOI":"10.21769\/BioProtoc.4321","article-title":"Optimization of Extracellular Flux Assay to Measure Respiration of Anchorage-independent Tumor Cell Spheroids","volume":"12","author":"Javed","year":"2022","journal-title":"Bio-Protoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1038\/s41598-019-41941-4","article-title":"Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas","volume":"9","author":"Dawson","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32810","DOI":"10.18632\/oncotarget.9053","article-title":"Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease","volume":"7","author":"Haley","year":"2016","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: A web application for analyzing drug combination dose-response matrix data","volume":"33","author":"Ianevski","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: Visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Rosignol, I., Villarejo-Zori, B., Teresak, P., Sierra-Filardi, E., Pereiro, X., Rodr\u00edguez-Muela, N., Vecino, E., Vieira, H.L.A., Bell, K., and Boya, P. (2020). The mito-QC reporter for quantitative mitophagy assessment in primary retinal ganglion cells and experimental glaucoma models. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051882"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0092-8674(91)90534-6","article-title":"Brefeldin A\u2019s Effects on Endosomes, Lysosomes, and the TGN Suggest a General Mechanism for Regulating Organelle Structure and Membrane Traffic","volume":"67","author":"Yuan","year":"1991","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/emboj.2012.300","article-title":"OXPHOS mutations and neurodegeneration","volume":"32","author":"Koopman","year":"2013","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.devcel.2021.06.022","article-title":"MDVs to the rescue: How autophagy-deficient cancer cells adapt to defective mitophagy","volume":"56","author":"White","year":"2021","journal-title":"Dev. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.molcel.2023.08.021","article-title":"Mitochondrial degradation: Mitophagy and beyond","volume":"45 83","author":"Uoselis","year":"2023","journal-title":"Mol. Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1172\/JCI122035","article-title":"An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia","volume":"129","author":"Saito","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2016.04.020","article-title":"The Noncanonical Role of ULK\/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis","volume":"62","author":"Joo","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"17121","DOI":"10.1038\/s41598-018-35190-0","article-title":"GBF1 and Arf1 interact with Miro and regulate mitochondrial positioning within cells","volume":"8","author":"Walch","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.15252\/embj.201489899","article-title":"Old dog, new tricks: Arf1 required for mitochondria homeostasis","volume":"33","author":"Rabouille","year":"2014","journal-title":"EMBO J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41556-024-01518-4","article-title":"ARF1 compartments direct cargo flow via maturation into recycling endosomes","volume":"26","author":"Stockhammer","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41416-019-0651-y","article-title":"Oncogenic pathways and the electron transport chain: A dangeROS liaison","volume":"122","author":"Raimondi","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e133247","DOI":"10.1172\/jci.insight.133247","article-title":"Phase II clinical trial of metformin as a cancer stem cell\u2013targeting agent in ovarian cancer","volume":"5","author":"Brown","year":"2020","journal-title":"JCI Insight"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2016.06.006","article-title":"Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning","volume":"105","author":"Gadducci","year":"2016","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"40767","DOI":"10.18632\/oncotarget.8194","article-title":"Repurposing metformin for cancer treatment: Current clinical studies","volume":"7","author":"Chae","year":"2016","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"113214","DOI":"10.1016\/j.biopha.2022.113214","article-title":"Cytotoxic effect of metformin on butyrate-resistant PMF-K014 colorectal cancer spheroid cells","volume":"151","author":"Nittayaboon","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1746\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:21:57Z","timestamp":1780028517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18111746"],"URL":"https:\/\/doi.org\/10.3390\/cancers18111746","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}